M16.31 identifies unilateral osteoarthritis of the right hip that developed as a direct consequence of hip dysplasia — distinct from primary or post-traumatic OA — and is fully billable for FY2026.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- Hip
Documentation tips
What should appear in the chart to support M16.31.
Source · Editorial brief grounded in 6 cited references ↓
- Explicitly document the causal relationship: note that the right hip OA developed as a result of hip dysplasia, not as primary or post-traumatic OA.
- Include imaging findings that confirm both the dysplastic anatomy (e.g., lateral center-edge angle, acetabular index) and the OA changes (joint space narrowing, osteophytes, subchondral sclerosis).
- Specify laterality as 'right hip' by name in the assessment and plan — do not rely on the imaging report alone to establish it.
- Document conservative care history (physical therapy, activity modification, NSAIDs, intra-articular injections) to support medical necessity if THA authorization is anticipated.
- If congenital hip dysplasia has previously been coded (Q65.xx), ensure continuity in the record connecting that history to the current degenerative diagnosis.
Related CPT procedures
Procedure codes commonly billed with M16.31. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M16.31 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M16.11 (unilateral primary OA, right hip) when the chart documents a dysplastic etiology — these are distinct etiologic categories and incorrect code selection can cause authorization mismatches for THA.
- Billing the non-billable parent M16.3 instead of the laterality-specific child code M16.31; most payers require the billable, specific code.
- Failing to distinguish M16.31 (OA caused by dysplasia) from Q65.xx (congenital hip dysplasia without stated OA) — if both diagnoses are active and documented, both codes may be appropriate as dual diagnoses.
- Assuming M16.31 applies to left-hip dysplastic OA — left hip maps to M16.32; swapping laterality creates a clinical-record mismatch that flags on audit.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
Use M16.31 when the patient's right hip osteoarthritis is attributable to underlying acetabular or hip dysplasia, not incidental degenerative wear. The dysplastic anatomy — typically shallow acetabular coverage or abnormal femoral head-neck geometry — drives eccentric loading that accelerates cartilage breakdown. The causal relationship between the dysplasia and the OA must be established by the treating clinician, not inferred from imaging alone.
This code sits under parent M16.3 (non-billable) and is the right-sided counterpart to M16.32 (left hip) and M16.2 (bilateral dysplastic OA). If laterality is undocumented or the hip affected is not specified as right, drop to M16.30 (unilateral, unspecified side) or M16.3 per payer tolerance — though specificity to M16.31 is always preferred and required for many surgical authorizations. Do not use M16.31 for primary OA of the right hip without a documented dysplastic etiology; that maps to M16.11.
M16.31 is frequently the diagnosis driving total hip arthroplasty (THA) authorization in dysplasia patients. Payers cross-reference this code against CMS LCD L36007 for lower extremity major joint replacement — failure to document the dysplastic etiology, imaging confirmation of acetabular dysplasia, and conservative care failure can trigger medical necessity denials even with a clean procedure code pairing.
Sibling codes
Other billable codes under M16.3 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What is the difference between M16.31 and M16.11?
02Can M16.31 and a Q65 congenital dysplasia code be reported together?
03Which CPT procedure codes most commonly pair with M16.31?
04What if the provider documents dysplasia but doesn't explicitly state it caused the OA?
05Is M16.31 appropriate for bilateral dysplastic OA affecting both hips?
06What imaging documentation best supports M16.31 for payer audit purposes?
07Does M16.31 require a 7th-character extension?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M15-M19/M16-/M16.31
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M16.31
- 04pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7502580/
- 05cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=56796&ver=31&bc=CAAAAAAAAAAA
- 06icdcodes.aihttps://icdcodes.ai/diagnosis/hip-dysplasia/documentation
Mira AI Scribe
Mira's AI scribe captures the treating clinician's attribution of right hip OA to dysplastic anatomy, pulls laterality from the note, and flags imaging findings (lateral center-edge angle, joint space narrowing, osteophyte formation) that anchor the dysplastic etiology. This prevents downgrade to M16.11 or the non-billable M16.3, and ensures the authorization package for THA includes the correct etiologic code required under LCD L36007.
See how Mira captures M16.31 documentation